Search Results 501-510 of 18297 for Lactation
2022; 29. Oberhelman-Eaton S, Chang A, Gonzalez C, Braith A, Singh RJ, Lteif A. Initiation of Gender-Affirming Testosterone Therapy in a Lactating Transgender ...
Pregnant, lactating, or intending to become pregnant during the study. Known untreated or active CNS metastases (progressing or requiring anticonvulsants or ...
Is female and is lactating or pregnant. Has hypersensitivity or allergies to vedolizumab or any of its excipients. Has withdrawn from Study MLN0002-2003 ...
Women who are pregnant or lactating. History of a cerebral vascular event (stroke or transient ischemic attack), unstable angina, myocardial infarction, or ...
Pregnant or lactating female. History of known HIV infection. Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral ...
Pregnancy or lactation. Active second malignancy other than minor treatment of indolent cancers. History of hypersensitivity to any of the study drug ...
Pregnancy or lactation/breastfeeding. 13. Use of food or drugs that are known potent cytochrome P450 3A4/5 (CYP3A4/5) inhibitors or inducers or P ...
Subjects who are pregnant or lactating. Subjects with an active severe infection that required anti-infective therapy or with an unexplained fever >38.5°C ...
Subjects may be of either sex, age as described in each protocol. Female subjects must be non-lactating and must either be at least two years post ...
Pregnant or lactating. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.